AMRYT PHARMA PLC - SPNR ADR (AMYT) Stock Earnings & Estimates
USA - NASDAQ:AMYT - US03217L1061 - ADR
14.7 USD
+0.01 (+0.07%)
14.7 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 17.095M 14.17% | 58.124M 240.01% | 182.607M 214.17% | 219.479M 20.19% | 313.101M 42.66% | 401.548M 28.25% | 538.523M 34.11% | 729.444M 35.45% | |
| EBITDA YoY % growth | -17.67M -8.11% | -20.12M -13.87% | -977K 95.14% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -18.037M -8.35% | -32.775M -81.71% | -45.442M -38.65% | N/A | N/A | N/A | N/A | N/A | |
| Operating Margin | -105.51% | -56.39% | -24.89% | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A 26.18% | N/A -162.06% | N/A 91.19% | 0.01 143.86% | 0.28 2,486.69% | 0.39 40.94% | 0.97 147.52% | 2.43 150.00% |
| Q4 / 21 | Q1 / 22 | Q2 / 22 | Q3 / 22 | Q4 / 22 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.11 140.83% | N/A | N/A | N/A | 0.30 164.73% |
| Revenue Q2Q % growth | 56.912M 33.84% | 61.84M 27.68% | 72.083M 14.85% | 82.176M 45.40% | 195.651M 243.78% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2021 Q2Q % growth | -0.07 80.00% | % | ||
| Q2 2021 Q2Q % growth | -0.04 93.33% | % | ||
| Q4 2020 Q2Q % growth | -0.28 -8.64% | -0.04 | -0.24 | -667.52% |
Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2021 Q2Q % growth | 56.519M 14.58% | 51.634M | 4.885M | 9.46% |
| Q2 2021 Q2Q % growth | 62.762M 35.89% | 51.243M | 11.519M | 22.48% |
| Q1 2021 Q2Q % growth | 48.432M 8.66% | 45.703M | 2.729M | 5.97% |
| Q4 2020 Q2Q % growth | 42.522M -13.10% | 42.596M | -74.17K | -0.17% |
| Q3 2020 Q2Q % growth | 49.326M | 37.504M | 11.822M | 31.52% |
| Q2 2020 Q2Q % growth | 46.185M 402.50% | 41.209M | 4.976M | 12.08% |
| Q4 2019 Q2Q % growth | 48.93M | 24.238M | 24.691M | 101.87% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |